Administration of ephrinB2-Fc-His or Fc-TNYL-RAW-GS in conjunction with RT reduced local tumor growth and improved overall mouse survival (Fig. 6B–D, Supplementary Fig. 10). This evidence concerns the gene EFNB2 and neoplasm.